IJCRR

IJCRR - 15(14), July, 2023

Pages: 02-05

Curcumin - Bio Conjugates as Chemotherapeutics: A Computational Study

Author: Ramesh Baboo

Category: Healthcare

[Download PDF]

Abstract:

Introduction: Numerous studies have shown that curcumin possesses multifunctional pharmacological properties inducing apoptosis in a variety of tumor cells.
Aim/Objectve: It is very significant work to investigate the quantitative structure activity relationship (QSAR) and inhibition mechanisms of these curcumin-related compounds.
Method: QSAR studies of curcumin-amino acid bioconjugates have been carried out for their chemotherapeutic or anticancer activity against skin cancer cells. Based on molecular descriptor calculated by DRAGON software for QSAR, some key structural factors responsible for chemotherapeutic activity of these compounds were revealed.
Results: The results have provided some useful theoretical references for understanding the mechanism of action, designing new curcumin-related compounds with chemotherapeutic activity and were predicted their activities prior to synthesis.
Conclusion: The curcumin - glutamoyl derivative appeared to be the most effective compound when tested for antiproliferative potential.

Keywords: Curcumin, QSAR, Chemotherapeutics, Bio conjugates, Antiproliferative, Computation

References:

1. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem. Pharmacol. 2008 Dec 1; 76(11):1590-611.
2. Abe Y, Hashimoto SH, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res. 1999 Jan 1; 39(1):41-47.
3. Masuda T, Jitoe A. Antioxidative and antiinflammatory compounds from tropical gingers: isolation, structure determination, and activities of cassumunins A, B, and C, new complex curcuminoids from Zingiber cassumunar. J. Agric. Food Chem. 1994 Sep;42(9):1850-56.
4. Mishra S, Narain U, Mishra R, Misra K. Design, development and synthesis of mixed bioconjugates of piperic acid–glycine, curcumin–glycine/alanine and curcumin–glycine– piperic acid and their antibacterial and antifungal properties. Bioorg. Med. Chem. 2005 Mar 1;13(5):1477-86.
5. Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N et al. Retracted: Curcumin (diferuloylmethane) inhibits constitutive active NF?κB, leading to suppression of cell growth of human T?cell leukemia virus type I?infected T?cell
lines and primary adult T?cell leukemia cells. International journal of cancer (IJC). 2006 Feb 1;118(3):765-72.
6. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life Sci. 2008 Jun;65:1631-52.
7. Kunwar A, Barik A, Mishra B, Rathinasamy K, Pandey R, Priyadarsini KI. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochimica et Biophysica Acta (BBA)-General Subjects. 2008 Apr 1;1780(4):673-09.
8. Parvathy KS, Negi PS, Srinivas P. Curcumin–amino acid conjugates: synthesis, antioxidant and antimutagenic attributes. Food Chem. 2010 May 15;120(2):523-30.
9. Dubey SK, Sharma AK, Narain U, Misra K, Pati U. Design, synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties. Eur. J. Med. Chem. 2008 Sep 1;43(9):1837-46.
10. Singh RK, Rai D, Yadav D, Bhargava A, Balzarini J, De Clercq E. Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid. Eur. J. Med. Chem. 2010 Mar 1;45(3):1078-86.
11. Liu Z, Tang L, Zou P, Zhang Y, Wang Z, Fang Q et al. Synthesis and biological evaluation of allylated and prenylated mono- carbonyl analogs of curcumin as anti-inflammatory agents. Eur. J. Med. Chem. 2014 Mar 3;74:671-82.
12. Hansch C, Fujita T. p-σ-π Analysis; a Method for the Correlation of Biological Activity and Chemical Structure. J. Am. Chem. Soc. 1964 Apr; 86(8):1616-26.
13. Free SM, Wilson JW. A mathematical contribution to structureactivity studies. Eur. J. Med. Chem. 1964 Jul;7(4):395-09.
14. Cramer RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc.1988 Aug;110(18):5959-67.
15. Rajasekhar Reddy A, Dinesh P, S Prabhakar A, Umasankar K, Shireesha B, Bhagavan Raju M. A comprehensive review on SAR of curcumin. Mini-Rev. Med. Chem. 2013 Oct 1;13(12):1769-77.
16. Fuchs JR, Pandit B, Bhasin D, Etter JP, Regan N, Abdelhamid D et al. Structure–activity relationship studies of curcumin analogues. Bioorganic Med. Chem. Lett. 2009 Apr 1;19(7):2065-69.
17. Agrawal R, Mishra B, Tyagi E, Nath C, Shukla R. Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat. Pharmacol. Res. 2010 Mar 1;61(3):247-52.
18. Ishida J, Ohtsu H, Tachibana Y, Nakanishi Y, Bastow KF, Nagai M et al. Antitumor agents. Part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents. Bioorg. Med. Chem. 2002 Nov 1;10(11):3481-87.
19. Steward WP, Gescher AJ. Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research. Mol. Nutr. Food Res. 2008 Sep;52(9):1005-09.
20. Kumar A, Bora U. Molecular docking studies on inhibition of Stat3 dimerization by curcumin natural derivatives and its conjugates with amino acids. Bioinformation. 2012;8(20):988-93